1 Grant
2023
Development of a cellular therapy product with single specificity and improved persistence to prevent immunity to biotherapeutics
Biswas, Moanaro
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R21HL170146-01), $212,212USD, 2023-08-01 -- 2025-07-31